Aurinia Pharmaceuticals (AUPH) Shares Outstanding (2015 - 2026)

Aurinia Pharmaceuticals (AUPH) has 7 years of Shares Outstanding data on file, last reported at $130.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding fell 5.06% year-over-year to $130.8 million; the trailing twelve-month figure through Mar 2026 stood at $130.8 million (down 5.06% YoY), and the FY2025 full-year result was $132.3 million, down 6.08% from the prior year.
• Shares Outstanding for Q1 2026 stood at $130.8 million, down from $132.3 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $143.8 million in Q4 2023 and bottomed at $130.8 million in Q1 2026.
• The 5-year median for Shares Outstanding is $142.1 million (2022), against an average of $139.9 million.
• The widest annual swing landed in 2022, when Shares Outstanding climbed 10.63%; it then fell 7.87% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $142.3 million in 2022, then climbed by 1.1% to $143.8 million in 2023, then slipped by 2.05% to $140.9 million in 2024, then declined by 6.08% to $132.3 million in 2025, then dropped by 1.17% to $130.8 million in 2026.
• The last three Shares Outstanding figures came in at $130.8 million (Q1 2026), $132.3 million (Q4 2025), and $131.8 million (Q3 2025), per Business Quant data.

Peer Comparison